RXST (RxSight, Inc.) Stock Financials & Earnings | Market Cap Arena

RXST (RxSight, Inc.) Stock Financials & Earnings | Market Cap Arena

RXSTRxSight, Inc.

Mkt Cap$313M

Healthcare·Medical - Devices·🇺🇸 United States·NASDAQ

Revenue (TTM)$134M

Net Income (TTM)-$39M

EPS (TTM)-$0.95

Free Cash Flow (TTM)$0

Gross Margin76.6%

Op. Margin-35.8%

Net Margin-29.0%

FCF Margin0.0%

P/S Ratio (TTM)2.3x

P/E Ratio (TTM)—

YoY Rev Growth-10.4%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$17M	$10M	-$13M
Q2 23	$21M	$12M	-$14M
Q3 23	$31M	$14M	-$13M
Q4 23	$29M	$18M	-$11M
Q1 24	$30M	$21M	-$11M
Q2 24	$35M	$24M	-$8M
Q3 24	$45M	$25M	-$9M
Q4 24	$40M	$29M	-$9M
Q1 25	$38M	$28M	-$11M
Q2 25	$34M	$25M	-$14M
Q3 25	$30M	$24M	-$12M
Q4 25	$33M	$25M	-$11M

Valuation

Quarter	P/S	P/E
Q1 23	5.4x	—
Q2 23	4.7x	—
Q3 23	3.7x	—
Q4 23	3.2x	—
Q1 24	2.9x	—
Q2 24	2.5x	—
Q3 24	2.3x	—
Q4 24	2.1x	—
Q1 25	2.0x	—
Q2 25	2.0x	—
Q3 25	2.2x	—
Q4 25	2.3x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$18M	-$19M
Q2 23	-$8M	-$9M
Q3 23	-$8M	-$9M
Q4 23	-$10M	-$11M
Q1 24	-$9M	-$11M
Q2 24	-$4M	-$6M
Q3 24	$730K	-$373K
Q4 24	-$4M	-$5M
Q1 25	-$9M	-$9M
Q2 25	-$4M	-$6M
Q3 25	-$1M	-$2M
Q4 25	$14M	$17M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$747K
Q2 23	$2M
Q3 23	$653K
Q4 23	$2M
Q1 24	$2M
Q2 24	$2M
Q3 24	$1M
Q4 24	$847K
Q1 25	$575K
Q2 25	$2M
Q3 25	$581K
Q4 25	$3M

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	+95.6%	+19.9%
Q2 23	+83.2%	+26.8%
Q3 23	+143.1%	+51.1%
Q4 23	+77.6%	+26.9%
Q1 24	+68.7%	+31.4%
Q2 24	+67.6%	+25.5%
Q3 24	+48.1%	+26.5%
Q4 24	+40.7%	+23.9%
Q1 25	+28.4%	+20.9%
Q2 25	-3.6%	+10.2%
Q3 25	-33.2%	-22.2%
Q4 25	-18.9%	-10.0%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$3M	18.8%
Q2 23	$4M	19.0%
Q3 23	$4M	13.3%
Q4 23	$4M	15.5%
Q1 24	$5M	15.9%
Q2 24	$6M	17.5%
Q3 24	$7M	14.4%
Q4 24	$7M	18.1%
Q1 25	$7M	18.8%
Q2 25	$9M	25.4%
Q3 25	$8M	26.7%
Q4 25	-$24M	-73.0%

OpEx Breakdown

Quarter	R&D	SG&A
Q1 23	$7M	$16M
Q2 23	$7M	$18M
Q3 23	$7M	$19M
Q4 23	$7M	$21M
Q1 24	$8M	$23M
Q2 24	$8M	$24M
Q3 24	$9M	$26M
Q4 24	$9M	$28M
Q1 25	$10M	$29M
Q2 25	$10M	$29M
Q3 25	$9M	$27M
Q4 25	$9M	$28M

Revenue Segments

Quarter

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$11M	$143M	$154M
Q2 23	$9M	$138M	$147M
Q3 23	$10M	$122M	$132M
Q4 23	$10M	$117M	$127M
Q1 24	$33M	$93M	$125M
Q2 24	$24M	$209M	$233M
Q3 24	$17M	$220M	$237M
Q4 24	$17M	$221M	$237M
Q1 25	$28M	$201M	$229M
Q2 25	$40M	$187M	$227M
Q3 25	$30M	$198M	$228M
Q4 25	$20M	$208M	$228M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	32M	+13.0%
Q2 23	34M	+9.0%
Q3 23	36M	+3.4%
Q4 23	36M	+0.8%
Q1 24	37M	+2.5%
Q2 24	38M	+4.4%
Q3 24	40M	+3.5%
Q4 24	40M	+1.4%
Q1 25	41M	+0.4%
Q2 25	41M	+0.6%
Q3 25	41M	+0.5%
Q4 25	41M	+0.5%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 19	—	—
FY 20	—	—
FY 21	$102K	221
FY 22	$168K	292
FY 23	$305K	292
FY 24	$281K	498
FY 25	$292K	461